Editor of Patient Care Online.
Obesity in America: Highs and Lows by State
From highest percentage of children with obesity to lowest percentage of adults with hypercholesterolemia, see how obesity hits home in our new slideshow.
Cutting Daily Sodium Intake Significantly Lowers Blood Pressure in 1 Week, According to New Research
AHA 2023: Reducing daily sodium intake by about 4000 mg significantly lowered SBP in approximately 73% of adults in 1 week when compared to a higher sodium diet.
Systolic BP Target of <120 mm Hg Reduces CV Event Risk, According to New Data from AHA Scientific Sessions 2023
AHA 2023: An intensive 3-year treatment targeting SPB <120 mm Hg resulted in 39% lower CV mortality than standard treatment in patients with HTN at high risk of CVD.
Daily Dose: Novel “Triagonist” Resolves Steatosis in Patients with MASLD and Obesity
Your daily dose of the clinical news you may have missed.
Hypertension Treatment Options in Patients with Obesity
Which hypertension treatment options should be used as first-line therapy in patients with obesity? A clinician's answer and explanation, here.
Daily Dose: Global Disparities in Asthma Prevalence
FIB-4 Risk-Stratification Algorithm for MASLD Improved Primary Care Practice Patterns, According to New Research
TLM 2023: Primary care clinicians exposed to a FIB4-based risk stratification algorithm reported applying it routinely for patients with elevated LFTs after the introduction.
New Data Show Rise in Decompensated Cirrhosis and Hepatic Encephalopathy Cases among US Medicare Beneficiaries
TLM 2023: Over 15 years, decompensated cirrhosis and OHE notably rose among Medicare beneficiaries with cirrhosis, exceeding 40% and 20% in 2020.
New Research Reveals Underestimation of Overt Hepatic Encephalopathy Hospitalizations in US
TLM 2023: Relying solely on a primary diagnosis for overt hepatic encephalopathy underestimates the actual rate, length of stay, and costs of OHE hospitalizations.
STUDY: Novel “Triagonist” Retatrutide Resolved Steatosis in Over 85% of Patients with MASLD and Obesity
TLM 2023: In participants with metabolic dysfunction-associated steatotic liver disease, retatrutide 8 mg and 12 mg resolved steatosis in >85% of subjects.
Obesity is a Key Risk Factor for Hypertension, but Comorbidities Complicate the Relationship
President of the Alabama Obesity Society, Dr Jonathan Parker, discusses obesity as a risk factor for hypertension.
Daily Dose: US Adults Don't Discuss OTC Pain Relievers with Clinicians Despite Hypertension Risk
Daily Dose: Arexvy May Protect Adults Aged 50-59 Years at Increased Risk for RSV
E-Cigarette Use among High School Students Dropped in 2023, but More Work is Needed
New data from the 2023 National Youth Tobacco Survey shows current use of a tobacco product fell among high school students, potentially due to a drop in vape use.
Daily Dose: Variation in Post-ED Follow-Up Visits for Acute Bronchiolitis Across US States
Daily Dose: Possible Impact of RSVpreF Maternal Vaccine for RSV Prevention in Infants
Vaccination in America: Highs and Lows by State
Get a quick look at the 5 states ranking highest and lowest on metrics including flu vaccination, tetanus vaccination, HPV vaccination, and more.
US Adults Don’t Discuss Effects of Pain Relievers with Clinicians Despite Link to Increased Blood Pressure
Only about 30% of more than 3000 adults surveyed in new poll reported talking to their clinician about the adverse effects OTC pain medications can have on blood pressure.
Daily Dose: Tirzepatide Preferred GLP-1 Agonist for Inducing Weight Loss
Remdesivir Linked to Lower Mortality in Patients with COVID-19 Requiring Supplemental Oxygen
Remdesivir use was associated with increased survival among patients hospitalized with COVID-19 requiring supplemental oxygen across SARS-CoV-2 variants of concern, report researchers.
Daily Dose: Next Generation Cologuard for Colorectal Cancer Detection
Daily Dose: Hydrocortisone Outperforms Other Corticosteroids for Community-Acquired Pneumonia
Daily Dose: Novel Intranasal COVID-19 Vaccine Induces Strong Immune Response
Daily Dose: Obesity Linked to Higher Risk for Breast Cancer Recurrence
Daily Dose: Real-World Use of Cabotegravir for HIV PrEP
Infectious Disease & Primary Care: A Conversation with IDWeek 2023 Chair
Listen to our latest podcast episode with Heather Yun, MD, for details on emerging pathogens, the role of primary care clinicians in the effort to rein in antimicrobial resistance, and more.
Daily Dose: Obesity Before and During Pregnancy Predicts Future CV Health
Hydrocortisone Bests Other Corticosteroids for Community-Acquired Pneumonia in New Analysis
Data presented at CHEST 2023 shows treatment with hydrocortisone is associated with a decrease in morality among patients with community-acquired pneumonia.
Daily Dose: Social Risk Factors for RSV Hospitalization in Older Adults
Obesity and Hypertension: It’s a Complicated Relationship, Says One Clinician
President of the Alabama Obesity Society, Dr Jonathan Parker, provides an in-depth overview of the association between obesity and hypertension.